Össur hf. - Financial Statement Release

Ossur hf. - First Quarter Report 2009

First Quarter 2009 Financial Highlights


  * Sales USD 77.2 million, down by 13%, down by 4% measured in LCY
  * EBITDA USD 12.9 million, down by 26%*
  * EBITDA margin 17%, compared to 20%* in Q1 2008
  * Net profit USD 7.6 million, compared to USD 6.7 million in Q1
    2008
  * EPS diluted 1.79 US cents, compared to 1.58 US cents in Q1 2008
  * Cash EPS diluted 2.98 US cents, the same as in Q1 2008


Jon Sigurdsson, President & CEO, comments:"The first quarter shows slower sales than anticipated, declining by
4% measured  in  local  currency.  Sales in  the  first  quarter  are
affected by the slowdown  in the economy, in  all our major  markets.
Sales in prosthetics  are in line  with the market  whereas sales  of
bracing and supports in the  Americas continue to be challenging.  We
have made some extensive changes in  the leadership in the sales  and
marketing in  the  Americas which  we  believe will  return  positive
results for  this  segment.  In  2009 we  have  an  exciting  product
pipeline and in the first quarter two new products were introduced."


*NOTE: Excluding one-time gain in Q1 2008

The press release including tables, the Investor Presentation Q1 2009
and the Financial Statement Q1 2009 can be downloaded from the
following links:

Attachments:

Ossur Q1 2009 Investor presentation.pdf

Ossur Q1 2009 Financial Statement.pdf

Ossur Q1 2009 Press Release.pdf